US equities |
NVDA $186.64 ▲+2.78% MU $690.00 ▲+5.12% AMD $449.04 ▲+11.04% SPCX $134.27 ▲+8.62% AAPL $342.37 ▼-0.52% SNDK $835.06 ▲+3.55% MSFT $530.61 ▼-0.99% TSLA $358.22 ▲+4.23%
FinancialContent

Hemogenyx Pharmaceuticals Plc. (OP:HOPHF)

2.330 UNCHANGED
Last Price Updated: 12:20 PM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hemogenyx Pharmaceuticals Plc.

< Previous 1 2 3 4 Next >
News headline image
Hemogenyx Pharmaceuticals PLC Announces Single CBR Can Treat Multiple Viruses
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Process Qualification Run Completed
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC - HEMO-CAR-T First PQ Run Completed
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Process Development Runs Completed
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Half-year Report
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Appointment of Director of Quality
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Approval and Issuance of Antibody Patent
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Appointment of Medical Director
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Presentation at H.C. Wainwright Global Conference
Via ACCESSWIRE
< Previous 1 2 3 4 Next >